Comprehensive Kidney Function Assessment and Early Warning in Older Adults
NCT07765134
Chronic Disease, Chronic Kidney Disease
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT Number: NCT05866276
To determine the accuracy of SCreening for Occult REnal Disease (SCORED) questionnaire for CKD risk among Asian Patients
Looking for future studies?
Notify MeAll sexes
Observational
Perisai Husada, Bandung, West Java, Indonesia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-
Exclusion criteria
-
Time frame: 28 February 2024
The primary objective is to evaluate the accuracy of SCORED tool in identifying individuals at risk for the development of CKD in the Asian population. The primary outcomes, sensitivity, and specificity will be summarised using percentage and 95% confidence intervals to be measured at Baseline up to 6months after enrollment
AstraZeneca
Industry
A Real-World Multicentre Prospective Study to Determine the Accuracy of the SCORED (SCreening for Occult REnal Disease) Questionnaire for SCreening REnal Risk Early Against Nephropathy in Adult Population in Asia
Acronym: SCREEN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07765134
Chronic Disease, Chronic Kidney Disease
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT06833541
Chronic Disease, Chronic Kidney Disease
Changsha, Hunan, China
View Trial DetailsNCT05504850
Chronic Disease, Chronic Kidney Disease
The Bronx, New York, United States
View Trial DetailsNCT07747363
Cardiovascular Diseases, Chronic Disease
Austin, Texas, United States
View Trial Details